NCT04369833View on ClinicalTrials.gov

Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

May 11, 2020

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
PreDiabetesGlucose Metabolism DisordersDiabetes Mellitus
Interventions
DEVICE

continuous glucose monitoring system

wearing continuous glucose monitoring device (iPro2 professional continuous glucose monitoring, MedtronicⓇ, California, USA)

Trial Locations (1)

49241

Pusan national university hospital, Busan

All Listed Sponsors
lead

Pusan National University Hospital

OTHER

NCT04369833 - Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform | Biotech Hunter | Biotech Hunter